Japan Tokyo Pharmaceutical Raw Materials Exhibition（CPhI Japan）has been held since 2002 and is one of the pharmaceutical raw material series exhibitions held worldwide. Exhibitors have the opportunity to showcase their latest pharmaceutical raw materials, technologies, and solutions. This includes various pharmaceutical raw materials, formulations, biologics, synthetic drugs, production equipment, packaging materials, and pharmaceutical process technologies, among others. Additionally, there are displays and discussions on drug research and development, production, quality control, and regulatory compliance.

Exhibiting from 31 countries and regions, 712 companies participated, with approximately 20,000 pharmaceutical personnel from around 20 countries and regions attending to discuss pharmaceutical development and present the latest technologies. Starting from 2023, CPHI has been rebranded, serving as a one-stop exhibition for pharmaceutical development from drug discovery to manufacturing, supporting new drug development and stable supply.

Japan Tokyo Pharmaceutical Raw Materials Exhibition（CPhI Japan）typically includes a series of seminars, lectures, and thematic discussions aimed at delving into the latest developments, market trends, innovative research, and regulatory dynamics in the pharmaceutical industry. These activities provide participants with an opportunity to gain in-depth insights into the pharmaceutical field.

In the Japanese pharmaceutical industry, where the market growth rate is expected to remain low, in addition to expecting the development of new anti-cancer agents as the dominant players in the market, efforts are being made to explore the development of biopharmaceuticals such as nucleic acids, peptides, gene therapy, cell medicine, digital health, and new lifestyles including 'staying put'.

In recent years, with the prolonged development cycle of the pharmaceutical industry and increasing development costs year by year, outsourcing to CMOs (Contract Manufacturing Organizations) and CDMOs (Contract Development and Manufacturing Organizations) in the development and manufacturing sectors has increased in order to focus on drug development and other research areas. Particularly in the biopharmaceutical sector, which has many venture companies, collaboration with external partners is inevitable.

To meet the needs of the industry, the Tokyo, Japan Tokyo Pharmaceutical Raw Materials Exhibition（CPhI Japan）will provide the latest technological trends and technical experience domestically and internationally through the exhibition and conferences. (The content of this article belongs to Juzhan.com, and it is forbidden to forward without permission.)